Synthesis of novel fluorinated 1,5-benzothiazepine derivatives and their biological evaluation as anticancer and antibacterial agents Scientific paper

Main Article Content

Sonal R. Bhabal
https://orcid.org/0000-0001-8501-9904
Sarfaraz F. Shaikh
https://orcid.org/0000-0001-6082-2506
Ishita P. Yellapurkar
https://orcid.org/0000-0002-8822-5057
Ganesh S. Pavale
https://orcid.org/0000-0002-0592-4339
Mucheli V. Ramana
https://orcid.org/0000-0002-2220-8019

Abstract

A series of novel fluorinated 1,5-benzothiazepine derivatives were synthesized, characterized and evaluated for in vitro anticancer and antibac­terial activity. The in vitro anticancer activity of the synthesized compounds 4ah was evaluated against four human cancer cell lines namely lung (A549), breast (MCF-7), liver (HEPG2) and prostate (PC-3). Compounds 4c, 4d, 4g and 4h exhibited good activity with GI50 <10 µg ml-1 against all four human cancer cell lines which was comparable to standard drug adriamycin. Addition­ally, antibacterial activity of synthesized compounds was estimated using Res­azurin Microtiter Assay (REMA) and compared with standard drug ampicillin. Among the synthesized compounds, 4c, 4d, 4g and 4h showed good antibac­terial activity and all the synthesized compounds were found to be more active towards gram negative than gram positive bacteria. These promising results obtained from in vitro anticancer and antibacterial activity, inferred that the synthesized compounds are capable of being anticancer as well as antibacterial agents.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
S. R. Bhabal, S. F. Shaikh, I. P. Yellapurkar, G. S. Pavale, and M. V. Ramana, “Synthesis of novel fluorinated 1,5-benzothiazepine derivatives and their biological evaluation as anticancer and antibacterial agents: Scientific paper”, J. Serb. Chem. Soc., vol. 87, no. 10, pp. 1109–1116, May 2022.
Section
Organic Chemistry

References

H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA. Cancer J. Clin. (2021) 1 (https://doi.org/10.3322/caac.21660)

A. Kamal, D. Dastagiri, M. Janaki Ramaiah, J. Surendranadha Reddy, E. Vijaya Bharathi, M. Kashi Reddy, M. Victor Prem Sagar, T. Lakshminarayan Reddy, S. N. C. V. L. Pushpavalli, M. Pal-Bhadra, Eur. J. Med. Chem. 46 (2011) 5817 (https://doi.org/10.1016/j.ejmech.2011.09.039)

B. Mansoori, A. Mohammadi, S. Davudian, S. Shirjang, B. Baradaran, Adv. Pharm. Bull. 7 (2017) 339 (https://doi.org/10.15171/apb.2017.041)

S. Bhat, S. Muthunatarajan, S. S. Mulki, K. Archana Bhat, K. H. Kotian, Int. J. Microbiol. 2021 (2021) (https://doi.org/10.1155/2021/8883700)

R. J. Fair, Y. Tor, Perspect. Medicin. Chem. (2014) 25 (https://doi.org/10.4137/PMC.S14459)

S. G. Jagadhani, S. G. Kundlikar, B. K. Karale, Orient. J. Chem. 31 (2015) 601 (https://doi.org/10.13005/ojc/310177)

F. L. Ansari, S. Umbreen, L. Hussain, T. Makhmoor, S. A. Nawaz, M. A. Lodhi, S. N. Khan, F. Shaheen, M. I. Choudhary, Atta-ur-Rahman, Chem. Biodivers. 2 (2005) 487 (https://doi.org/10.1002/cbdv.200590029)

A. B. Shaik, P. R. Yejella, S. Nissankararao, S. Shahanaaz, Anticancer. Agents Med. Chem. 20 (2020) 1115 (https://doi.org/10.2174/1871520620666200130091142)

K. L. Ameta, N. S. Rathore, B. Kumar, J. Serb. Chem. Soc. 77 (2012) 725 (https://doi.org/10.2298/JSC110715219А)

A. Sharma, G. Singh, A. Yadav, L. Prakash, Molecules 2 (1997) 129 (https://doi.org/10.3390/20900129)

V. R. Vutla, R.P. Yejella, R. Nadendla Int. J. Pharm. Sci. Res. 5 (2014) 453 (http://dx.doi.org/10.13040/IJPSR.0975-8232.5(2).453-62)

M. Mostofi, G. Mohammadi Ziarani, N. Lashgari, Bioorganic Med. Chem. 26 (2018) 3076 (https://doi.org/10.1016/j.bmc.2018.02.049)

G. Singh, N. Kumar, A. K. Yadav, A. K. Mishra, Heteroat. Chem. 13 (2002) 620 (https://doi.org/10.1002/hc.10051)

B. V. Kendre, M. G. Landge, S. R. Bhusare, Arab. J. Chem. 12 (2019) 2091 (https://doi.org/10.1016/j.arabjc.2015.01.007)

G. De Sarro, A. Chimirri, A. De Sarro, R. Gitto, S. Grasso, M. Zappalà, Eur. J. Med. Chem. 30 (1995) 925 (https://doi.org/10.1016/0223-5234(96)88311-5)

R. Di Santo, R. Costi, Farmaco 60 (2005) 385 (https://doi.org/10.1016/j.farmac.2005.03.006)

G. Grandolini, L. Perioli, V. Ambrogi, Eur. J. Med. Chem. 34 (1999) 701 (https://doi.org/10.1016/S0223-5234(99)00223-8)

S. A. Nawaz, S. Umbreen, A. Kahlid, F. L. Ansari, M. I. Choudhary, J. Enzyme Inhib. Med. Chem. 23 (2008) 206–212 (https://doi.org/10.1080/14756360701533080)

F. L. Ansari, F. Iftikhar, Ihsan-ul-Haq, B. Mirza, M. Baseer, U. Rashid, Bioorg. Med. Chem. 16 (2008) 7691 (https://doi.org/10.1016/j.bmc.2008.07.009)

D. M. Lokeshwari, N. D. Rekha, B. Srinivasan, H. K. Vivek, A. K Kariyappa, Bioorg. Med. Chem. Lett. 27 (2017) 3048 (https://doi.org/10.1016/j.bmcl.2017.05.059)

N. C. Desai, H. V. Vaghani, B. Y. Patel, T. J. Karkar, Ind. J. Pharm. Sci. 80 (2018) 242 (https://doi.org/10.4172/pharmaceutical-sciences.1000351)

H. J. Böhm, D. Banner, S. Bendels, M. Kansy, B. Kuhn, K. Müller, U. Obst-Sander, M. Stahl, ChemBioChem 5 (2004) 637 (https://doi.org/10.1002/cbic.200301023)

P. M. M. C. Rao, S. A. Rahaman, P. R. Yejella, Asian J. Pharm. Anal. Med. Chem. 4 (2016) 175

M. Upreti, S. Pant, A. Dandia, U. C. Pant, Phosphorus Sulfur Silicon Relat. Elem. 113 (1996) 165 (https://doi.org/10.1080/10426509608046387)

A. Dandia, M. Sati, A. Loupy, Green Chem. 4 (2002) 599 (https://doi.org/10.1039/b207004a)

H. Suwito, Jumina, Mustofa, P. Pudjiastuti, M. Z. Fanani, Y. Kimata-Ariga, R. Katahira, T. Kawakami, T. Fujiwara, T. Hase, H. M. Sirat, N. N. T. Puspaningsih, Molecules 19 (2014) 21473 (https://doi.org/10.3390/molecules191221473)

V. Vichai, K. Kirtikara, Nat. Protoc. 1 (2006) 1112 (https://doi.org/10.1038/nprot.2006.179)

S. F. Shaikh, P. P. Dhavan, P. R. Singh, S. P. Vaidya, B. L. Jadhav, M. M. V. Ramana Russ. J. Bioorg. Chem. 47 (2021) 571 (https://doi.org/10.1134/S1068162021020242).